Skip to main content
. 2019 Jul 4;182(1):180–189. doi: 10.1111/bjd.17918

Figure 1.

Figure 1

Maximum postdose titre values by antidrug antibody (ADA) patient category for all ADA‐evaluable patients through weeks 52–64. The boxes represent the interquartile range, the line in the box is the median and the whiskers are the 5th and 95th percentiles. TE‐POS, treatment emergent positive; NAb‐NEG, neutralizing antibody negative; NAb‐POS, neutralizing antibody positive.